Janus Henderson Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112M | Buy |
3,577,735
+252,642
| +8% | +$7.91M | 0.05% | 250 |
|
|
2025
Q1 | $114M | Buy |
3,325,093
+458,338
| +16% | +$15.7M | 0.06% | 247 |
|
|
2024
Q4 | $112M | Buy |
2,866,755
+314,363
| +12% | +$12.3M | 0.06% | 263 |
|
|
2024
Q3 | $101M | Buy |
2,552,392
+1,507,135
| +144% | +$59.3M | 0.05% | 279 |
|
|
2024
Q2 | $40.8M | Buy |
1,045,257
+103,688
| +11% | +$4.04M | 0.02% | 425 |
|
|
2024
Q1 | $40.5M | Sell |
941,569
-24,496
| -3% | -$1.05M | 0.02% | 431 |
|
|
2023
Q4 | $44.5M | Buy |
966,065
+583,760
| +153% | +$26.9M | 0.03% | 402 |
|
|
2023
Q3 | $13.1M | Buy |
382,305
+54,961
| +17% | +$1.88M | 0.01% | 612 |
|
|
2023
Q2 | $12.6M | Buy |
327,344
+5,879
| +2% | +$226K | 0.01% | 651 |
|
|
2023
Q1 | $11.5M | Buy |
321,465
+29,679
| +10% | +$1.06M | 0.01% | 683 |
|
|
2022
Q4 | $11.5M | Sell |
291,786
-175,882
| -38% | -$6.93M | 0.01% | 691 |
|
|
2022
Q3 | $16.9M | Buy |
467,668
+190,994
| +69% | +$6.89M | 0.01% | 709 |
|
|
2022
Q2 | $8.41M | Buy |
276,674
+266,393
| +2,591% | +$8.1M | 0.01% | 731 |
|
|
2022
Q1 | $315K | Buy |
+10,281
| New | +$315K | ﹤0.01% | 2188 |
|